Previous 10 | Next 10 |
Nevro (NYSE: NVRO ) reports preliminary Q1 2020 revenue is expected to be ~$86.4M - $86.9M, up 5-6% Y/Y; says Q1 revenue was negatively impacted by a rapid deceleration in March due to COVID-19 shelter-in-place policies and restrictions on elective surgical procedures More news on: Nevro C...
REDWOOD CITY, Calif. , April 1, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced preliminary unaudited worldwide revenue for the quarter ended Marc...
In a note, Morgan Stanley's David Lewis expects medical device companies to experience a rapid recovery over the next 6-12 months after an "acute impact" from effects of the COVID-19 pandemic (Q1 and probably Q2 are going to be ugly), adding that he does not see any significant liquidity iss...
The following slide deck was published by Nevro Corp. in conjunction with their 2019 Q4 earnings Read more ...
REDWOOD CITY, Calif. , Feb. 28, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it has filed a lawsuit for patent infringement against Nalu Me...
REDWOOD CITY, Calif. , Feb. 28, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the settlement of its patent infringement lawsuit against Stimwave ...
Healthcare Pulse Source: Bloomberg The fear of Coronavirus (Covid-19) has infected the stock market. The market's patience completely ran out this week as the Coronavirus news, which has continued to weigh heavily on the negative side, sent the market reeling in a feral pullback. Wha...
Nevro ( NVRO +5.6% ) hits all-time highs as Canaccord Genuity upgrades shares to Buy from Hold and raises its price target to $153 from $120. More news on: Nevro Corp., Healthcare stocks news, Stocks on the move, Read more ...
Nevro Corp (NVRO) Q4 2019 Earnings Conference Call February 25, 2020, 16:30 ET Company Participants Juliet Cunningham - VP, IR Keith Grossman - Chairman, CEO & President Andrew Galligan - CFO Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Dav...
Nevro (NYSE: NVRO ): Q4 GAAP EPS of -$0.44 beats by $0.19 . More news on: Nevro Corp., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...